NewslettersPancreatic Cell News Efficacy and Safety of Garsorasib in Patients with KRAS G12C-Mutated Advanced Pancreatic Cancer By Jamie Kang - December 8, 2025 0 46 Garsorasib demonstrated encouraging antitumor activity and a tolerable safety profile in patients with KRAS G12C-mutated advanced pancreatic cancer. [British Journal of Cancer] Abstract